INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹0.91 Cr | ₹0.14 Cr | ₹-0.08 Cr | ₹-0.07 Cr | ₹0.12 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDO US BIOTECH ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹0.91 Cr |
Mar2023 | ₹0.14 Cr |
Mar2022 | ₹-0.08 Cr |
Mar2021 | ₹-0.07 Cr |
Mar2020 | ₹0.12 Cr |
How is Net Cash Inflow / Outflow of INDO US BIOTECH Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹0.91 Cr | 544.68 | |
Mar2023 | ₹0.14 Cr | Positive | |
Mar2022 | ₹-0.08 Cr | Negative | |
Mar2021 | ₹-0.07 Cr | Negative | |
Mar2020 | ₹0.12 Cr | - |
Compare Net Cash Inflow / Outflow of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹317.0 Cr | -1% | -18.2% | -39.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹11,868.9 Cr | 0% | 4.6% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,929.1 Cr | 15.2% | 43.4% | 108.6% | Stock Analytics | |
VENKYS (INDIA) | ₹2,231.7 Cr | 1.1% | -0.1% | 1.6% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,298.6 Cr | 2.4% | -4.8% | -49.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹418.2 Cr | -9.3% | -12.6% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -1% |
-18.2% |
-39.7% |
SENSEX | -5.5% |
0.2% |
-1% |
You may also like the below Video Courses